Microfluidic-based prostate cancer model for investigating the secretion of prostate-specific antigen and microRNAs in vitro
Mucus production, host-microbiome interactions, hormone sensitivity, and innate immune responses modeled in human cervix chips
PD-1/PDL1 checkpoint inhibitors in combination with olarparib display antitumor activity in ovarian cancer patient-derived three-dimensional spheroid cultures